ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 21 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $29,000 | +1350.0% | 7,600 | +1410.9% | 0.00% | – |
| Q4 2019 | $2,000 | -71.4% | 503 | -96.2% | 0.00% | – |
| Q3 2019 | $7,000 | 0.0% | 13,280 | +188.6% | 0.00% | – |
| Q2 2019 | $7,000 | -53.3% | 4,601 | -44.9% | 0.00% | – |
| Q1 2019 | $15,000 | +650.0% | 8,350 | +542.3% | 0.00% | – |
| Q4 2018 | $2,000 | -98.4% | 1,300 | -95.9% | 0.00% | – |
| Q3 2018 | $123,000 | +324.1% | 32,017 | +491.0% | 0.00% | – |
| Q2 2018 | $29,000 | – | 5,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 194,963 | $506,904 | 0.07% |
| Newman Dignan & Sheerar, Inc. | 18,915 | $49,179 | 0.02% |
| BRAVE ASSET MANAGEMENT INC | 10,000 | $26,377 | 0.01% |
| Disciplined Investments, LLC | 5,189 | $13,491 | 0.01% |
| Long Focus Capital Management, LLC | 40,000 | $104,000 | 0.01% |
| HEADINVEST, LLC | 11,534 | $23,414 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $14,693 | 0.00% |
| Clearview Wealth Advisors LLC | 500 | $1,300 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $31 | 0.00% |
| CIBC WORLD MARKET INC. | 60,913 | $161 | 0.00% |